- Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome. Rossi, H.A., O'Donnell, J., Sarcinelli, F., Stewart, F.M., Quesenberry, P.J., Becker, P.S. Leukemia (2002)